Advertisement
Two new studies raise the possibility that statins may blunt the effectiveness of flu vaccines in seniors. The research is published online Oct. 28 in The Journal of Infectious Diseases.

Flu Vaccine Slightly Less Effective in Patients on Statins

0
Research suggests cholesterol-lowering meds linked to lower levels of influenza antibodies in seniors
All packs of Auvi-Q injectors are being recalled in the United States as some may not deliver the correct dose of epinephrine

Sanofi Recalls Auvi-Q Injectors Used to Treat Anaphylaxis

0
Injectors may not deliver right amount of drug
In patients with myofascial pain syndrome

Lidocaine, Hyaluronidase Mix Works Faster in Myofascial Pain

0
Findings following trigger point injections for treatment of myofascial pain syndrome
Cancer-associated incidental pulmonary embolism should be treated with low molecular weight heparins

Review Supports LMWH for Cancer-Linked Incidental PE

0
VTE recurrence risk similar under LMWHs, vitamin K antagonists; risk of major hemorrhage up under VKA
For patients with liver cirrhosis

Low-Dose Rifaximin Cuts Endotoxin Level in Cirrhosis

0
Similar reduction in serum endotoxin level for low-dose, high-dose rifaximin
Computed tomography findings affect the diagnosis and management of suspected community-acquired pneumonia

Early CT Scan Impacts Management of Suspected CAP

0
CT scan modified classification in 58.6 percent of patients presenting to ER with suspected CAP
Body mass index

Lifestyle Factors Not Linked to Chronic Prostatitis/Pelvic Pain

0
No correlations seen in large cohort study of U.S. male health professionals
Hidradenitis suppurativa can be associated with infectious and/or neoplastic fatal complications

Fatal Case of Hidradenitis Suppurativa Described

0
Case report describes fatal case of HS associated with sepsis and squamous cell carcinoma
For black patients with asthma treated with inhaled corticosteroids

LABAs No Better Than Tiotropium in Black Adults With Asthma

0
Outcomes similar for patients treated with inhaled corticosteroids plus tiotropium versus LABAs
A considerable proportion of federal marketplace plans lack at least one in-network specialist

Nearly 15 Percent of Plans Lack In-Network Specialists

0
Most commonly excluded specialists are in endocrinology, rheumatology, and psychiatry